Concepedia
Statistics
Publications
11
Citations
775
H-Index
10
Active since
2007
Affiliations
Sarah Cannon(Current)
Tennessee Oncology
Sarah Cannon Research Institute
C. Farley is an author at Sarah Cannon specializing in medicine, oncology, and chemotherapy.
Publications per year
2007–2010
Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab
David R. Spigel, John D. Hainsworth, Denise A. Yardley et al. · Journal of Clinical Oncology · 2009 · 298 citations
Medicine, Oncology, Pharmacotherapy +14
Phase II Trial of Bevacizumab and Erlotinib in Carcinomas of Unknown Primary Site: The Minnie Pearl Cancer Research Network
John D. Hainsworth, David R. Spigel, C. Farley et al. · Journal of Clinical Oncology · 2007 · 113 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
David R. Spigel, F. Anthony Greco, John D. Zubkus et al. · Journal of Thoracic Oncology · 2009 · 85 citations · Full text
Medicine, Oncology, Pharmacology +14
Treatment of Advanced Renal Cell Carcinoma with the Combination Bevacizumab/Erlotinib/Imatinib: A Phase I/II Trial
John D. Hainsworth, David R. Spigel, Jeffrey A. Sosman et al. · Clinical Genitourinary Cancer · 2007 · 80 citations
Medicine, Oncology, Pharmacology +8
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer
John D. Hainsworth, David R. Spigel, C. Farley et al. · Cancer · 2007 · 70 citations
Medicine, Oncology, Pharmacotherapy +12
1–5 of 11